Comment: Azithromycin for Gastroparesis

1. Potter TG , Snider KR . Azithromycin for the treatment of gastroparesis. Ann Pharmacother 2013; 47: 411–5. DOI: 10.1345/aph.1R541

2. Larson JM , Tavakkoli A , Drane WE , Toskes PP , Moshiree B . Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis. J Neurogastroenterol Motil 2010; 16: 407–13.

3. Moshiree B , McDonald R , Hou W , Toskes PP . Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci 2010; 55: 675–83.

4. Chini P , Toskes PP , Waseem S , Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility. Scand J Gastroenterol 2012; 47: 422–7.

5. Chini P , Toskes PP , Talley N , Comparison of two macrolides, azithromycin and erythromycin, for symptomatic treatment of gastroparesis (abstract 114). Gastroenterology 2011; 106: S46.

6. Moshiree B , Verne NG , Toskes PP . Azithromycin as a novel treatment for gastroparesis (abstract 889)? Am J Gastroenterol 2005; 100: S326.

7. Product label. Zithromax (azithromycin powder for suspension). New York, NY: Pfizer Labs. Revised April 2012. http://dailymed.nlm.nih.gov/dailymed/Lookup.cfm?setid=db52b91e-79f7-4cc1-9564-f2eee8e31c45 (accessed 2013 Mar 6).

8. Product label. Erypred 400 (erythromycin ethylsuccinate suspension). North Chicago, IL: Abbott Laboratories. Revised July 2012. http://dailymed.nlm.nih.gov/dailymed/Lookup.cfm?setid=63ab97a3-5f44-4881-f38b-960b4f474790 (accessed 2013 Mar 6).